BioPorto Appoints New President of BioPorto Diagnostics, Inc.
April 15, 2019 09:00 ET | BioPorto A/S
Company Plans to Bring Novel Kidney Diagnostic to US Market Hellerup, Denmark, April 15, 2019 (GLOBE NEWSWIRE) -- Today, BioPorto A/S CPH: BIOPOR (“BioPorto”) announces the appointment of Amy...
DiamiR Announces $1.5M SBIR Phase II Funding for Further Evaluation of the microRNA Biomarkers for Early Detection of Alzheimer's Disease
March 16, 2015 08:02 ET | DiamiR
MONMOUTH JUNCTION, NJ--(Marketwired - March 16, 2015) - DiamiR, LLC, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the National Institute...
ARUP Laboratories Adds Prosigna to Its Test Menu
March 05, 2014 13:34 ET | ARUP Laboratories
SALT LAKE CITY, March 5, 2014 (GLOBE NEWSWIRE) -- ARUP Laboratories announced on Monday, March 3, that it has added the Prosigna Breast Cancer Prognostic Gene Signature assay to its comprehensive...